Polymer Coated Liposomes for Drug Delivery to Target Specific Organs

  • Junzo Sunamoto
  • Kiyoshi Iwamoto
  • Masahiro Takada
  • Teruaki Yuzuriha
  • Kouichi Katayama


Liposomes have gained wide acceptance in chemotherapy as potential carriers in introducing drugs and macromolecules into cells. However, several problems to be overcome still remain before the liposomal drug-delivery system achieves its usefulness in biological and medicinal usages (1, 2). First of all is to depress the permeability of water soluble materials entrapped in liposomes, and the second is to access an ability for liposomes to specifically land onto the target cells or tissues.


Liposomal Membrane Liposome Suspension Substitution Degree Conventional Liposome Multilamellar Liposome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    D.A. Tyrell, T.D. Heath, C.M. Colley, B.E. Ryman, “New aspects of liposomes”, Biochim. Biophys. Acta, 457: 259 (1976).Google Scholar
  2. 2.
    G. Gregoriadis, “Liposomes in therapeutic and preventative medicine: The development of drug-carrier concept”, Ann. N.Y. Acad. Sci., 308: 343 (1978).PubMedCrossRefGoogle Scholar
  3. 3.
    H.J. Rogers, H.R. Perkins, J.B. Ward, “Microbial Cell Walls and Membranes”, Chapman and Hall, London, New York (1980).Google Scholar
  4. 4.
    A.L. Lehninger, “Biochemistry”, Worth Publisher Inc., New York (1975).Google Scholar
  5. 5.
    R.C. Hughes, “The complex carbohydrates of mammalian cell surfaces and their biological roles”, Essays Biochem., 11: 1 (1975).PubMedGoogle Scholar
  6. 6.
    N. Sharon, H. Lis, “Glycoproteins: research booming on long-ignored, ubiquitous compounds”, Chem. Eng. News, March 30: 21 (1981).CrossRefGoogle Scholar
  7. 7.
    W.S. Singleton, M.S. Gray, M.L. Brown, J.L. White, “Chromatographically homogeneous lecithin from egg phospholipids”, J. Am. Oil Chemists Soc., 42: 53 (1965).CrossRefGoogle Scholar
  8. 8.
    U. Hammerling, O. Westphal, “Synthesis and use of 0-stearoyl polysaccharides in passive hemagglutination and hemolysis”, Eur. J. Biochem., 1: 46 (1967).PubMedCrossRefGoogle Scholar
  9. 9.
    M. Suzuki, T. Mikami, T. Matsumoto, S. Suzuki, “Preparation and antitumor activity of O-palmitoyldextran phosphates, O-palmitoyldextrans, and dextran phosphate”, Carbohydr. Res., 53: 223 (1977).PubMedCrossRefGoogle Scholar
  10. 10.
    A.N. de Belder, K. Grahath, “Preparation and properties of fluorescein-labelled dextrans”, Carbohydr. Res., 30: 375 (1973).CrossRefGoogle Scholar
  11. 11.
    J. Sunamoto, H. Kondo, A. Yoshimatsu, “Liposomal membranes. I. Chemical damage of liposomal membranes with functional detergent”, Biochem. Biophys. Acta, 510: 52 (1978).PubMedCrossRefGoogle Scholar
  12. 12.
    J. Sunamoto, T. Hamada, H. Murase, “Liposomal membranes. IV. Fusion of liposomal membranes induced by several lipophilic agents”, Bull. Chem. Soc. Jpn., 53: 2773 (1980).CrossRefGoogle Scholar
  13. 13.
    R.J.L. Allen, “The estimation of phosphorus”, Biochem. J., 34: 858 (1940).PubMedGoogle Scholar
  14. 14.
    J.N. Weinstein, S. Yoshikami, P. Henkart, R. Blumenthal, W.A. Hagins, “Liposome-cell interaction: Transfer and intracellular release of a trapped fluorescent marker”, Science, 195: 489 (1977).PubMedCrossRefGoogle Scholar
  15. 15.
    F.C. Szoka, Jr., K. Jacobson, D. Papahadjopoulos, “The use of aqueous space markers to determine the mechanism of interaction between phospholipid vesicles and cells”, Biochim. Biophys. Acta, 551: 295 (1979).PubMedGoogle Scholar
  16. 16.
    M. Nakagaki, I. Yamamoto, “The interfacial reaction of lecithin and phsopholipase D at the micellar surface”, Yakugaku Zasshi, 101: 1099 (1981).PubMedGoogle Scholar
  17. 17.
    J. Sunamoto, K. Iwamoto, H. Kondo, “Liposomal membranes. VII. Fusion and aggregation of egg lecithin liposomes as promoted by polysaccharides”, Biochem. Biophys. Res. Commun., 94: 1367 (1980).PubMedCrossRefGoogle Scholar
  18. 18.
    C.A. Hunt, Y.M. Rustum, E. Mayhew, D. Papahadjopoulos, “Retention of cytosine alabinoside in mouse lung following intravenous administration in liposomes of different size”, Drug Metab. Dispos., 7: 124–129 (1979).PubMedGoogle Scholar
  19. 19.
    G.C. Ring, A.S. Blum, T. Kurbator, W.G. Moss, W. Smith, “Size of microspheres passing through pulmonary circuit in the dog”, Am. J. Physiol., 200: 1191–1198 (1961).PubMedGoogle Scholar
  20. 20.
    M.R. Mauk, R.C. Gamble, J.D. Baldeschwieler, “Targeting of lipid vesicles: specificity of carbohydrate receptor analogues for leukocytes in mice”, Proc. Natl. Acad. Sci. USA, 77: 4430 (1980).PubMedCrossRefGoogle Scholar
  21. 21.
    M.S. Wu, J.C. Robbins, R.L. Bugianesi, M.M. Ponpipom, T.Y. Shen, “Modified in vivo behavior of liposomes containing synthetic glycolipids”, Biochim. Biophys. Acta, 674: 19–29 (1981).PubMedGoogle Scholar
  22. 22.
    I.J. Fidler, A. Raz, W.E. Fogler, R. Kirsh, P. Bugelski, G. Poste, “Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages”, Cancer Res., 40: 4460–4466 (1980).PubMedGoogle Scholar

Copyright information

© Springer-Verlag US 1984

Authors and Affiliations

  • Junzo Sunamoto
    • 1
  • Kiyoshi Iwamoto
    • 1
  • Masahiro Takada
    • 2
  • Teruaki Yuzuriha
    • 2
  • Kouichi Katayama
    • 2
  1. 1.Department of Industrial Chemistry, Faculty of EngineeringNagasaki UniversityNagasakiJapan
  2. 2.Toyosato-machiEisai Co., Ltd.Tsukuba-gun, IbaragiJapan

Personalised recommendations